Morphine modulates proliferation of kidney fibroblasts

被引:60
作者
Singhal, PC
Sharma, P
Sanwal, V
Prasad, A
Kapasi, A
Ranjan, R
Franki, N
Reddy, K
Gibbons, N
机构
[1] Long Isl Jewish Med Ctr, Div Nephrol, Dept Med, New Hyde Pk, NY 11040 USA
[2] Albert Einstein Coll Med, Bronx, NY 10467 USA
关键词
morphine; fibroblasts; heroin-associated nephropathy; renal scarring HIV-associated nephropathy;
D O I
10.1046/j.1523-1755.1998.00758.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Renal interstitial scarring is an important component of heroin-associated nephropathy. Kidney fibroblasts have been demonstrated to play a role in the development of renal scarring in a variety of renal diseases. We studied the effect of morphine, an active metabolite of heroin, on the proliferation of kidney fibroblasts. Morphine at a concentration of 10(-12) M enhanced (P < 0.001) the proliferation of kidney fibroblasts (control, 67.5 +/- 2.0 vs. morphine, 112.2 +/- 10.1 x 10(4) cells/well). [H-3]thymidine incorporation studies further confirmed these results. Morphine at concentrations of 10(-12) M to 10(-10) M also modulated mRNA expression of early growth related genes (c-fos, c-jun and c-myc). Morphine at concentrations of 10(-8) to 10(-4) hr promoted apoptosis of kidney fibroblasts and also enhanced the synthesis of p53 by kidney fibroblasts. We speculate that morphine-induced kidney fibroblast proliferation may be mediated through the activation of early growth related genes, whereas morphine induced kidney fibroblast apoptosis may be mediated through the generation of p53. The present in vitro study provides a hypothetical basis for the role of morphine in the development of renal interstitial scarring in patients with heroin-associated nephropathy.
引用
收藏
页码:350 / 357
页数:8
相关论文
共 37 条
  • [1] CHAO CC, 1992, J PHARMACOL EXP THER, V262, P19
  • [2] HEROIN NEPHROPATHY - CLINICOPATHOLOGIC AND EPIDEMIOLOGIC-STUDY
    CUNNINGHAM, EE
    BRENTJENS, JR
    ZIELEZNY, MA
    ANDRES, GA
    VENUTO, RC
    [J]. AMERICAN JOURNAL OF MEDICINE, 1980, 68 (01) : 47 - 53
  • [3] DIFRANCESCO P, 1994, INT J TISSUE REACT, V16, P205
  • [4] NUCLEAR-CHANGES IN APOPTOSIS
    EARNSHAW, WC
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1995, 7 (03) : 337 - 343
  • [5] EISENSTEIN TK, 1991, ADV EXP MED BIOL, V288, P203
  • [6] FRANK J, 1993, EXP NEPHROL, V1, P26
  • [7] FRANKLIN TJ, 1986, J LAB CLIN MED, V108, P103
  • [8] DISAPPEARANCE OF UREMIA DUE TO HEROIN-ASSOCIATED NEPHROPATHY
    FRIEDMAN, EA
    RAO, TKS
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 25 (05) : 689 - 693
  • [9] C-MYC-INDUCED APOPTOSIS IN FIBROBLASTS IS INHIBITED BY SPECIFIC CYTOKINES
    HARRINGTON, EA
    BENNETT, MR
    FANIDI, A
    EVAN, GI
    [J]. EMBO JOURNAL, 1994, 13 (14) : 3286 - 3295
  • [10] CLINICAL IMPLICATIONS OF THE P53 TUMOR-SUPPRESSOR GENE
    HARRIS, CC
    HOLLSTEIN, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (18) : 1318 - 1327